-
1 Comment
Amrutanjan Health Care Limited is currently in a long term uptrend where the price is trading 26.2% above its 200 day moving average.
From a valuation standpoint, the stock is 21.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 5.8.
Amrutanjan Health Care Limited's total revenue rose by 21.0% to $1B since the same quarter in the previous year.
Its net income has increased by 121.1% to $210M since the same quarter in the previous year.
Finally, its free cash flow grew by 696.5% to $655M since the same quarter in the previous year.
Based on the above factors, Amrutanjan Health Care Limited gets an overall score of 4/5.
Exchange | NSE |
---|---|
CurrencyCode | INR |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
ISIN | INE098F01031 |
Beta | 0.6 |
---|---|
Target Price | None |
Dividend Yield | 0.8% |
Market Cap | 19B |
PE Ratio | 39.37 |
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; dental gel; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, the Southeast Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AMRUTANJAN.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025